Literature DB >> 21160768

Undefined familial colorectal cancer.

Constantinos Pantelis Zambirinis1, George Theodoropoulos, Maria Gazouli.   

Abstract

Colorectal cancer (CRC), one of the most common cancers of the world, is actually a spectrum of several subtypes, with different molecular profiles, clinico-pathological characteristics and possibly separate pathways of progression. It is estimated that in approximately 25%-35% of cases, a familial component exists, so they are classified as familial CRC (fCRC). However the known hereditary CRC syndromes justify only up to 5%. The rest are attributed to some inherited genetic predisposition passed to offspring through low-penetrance genes, which in the proper environmental setting can bring on tumorigenesis. Furthermore, part of the familial clustering may be attributed to chance. Because of the complexity regarding the etiology of CRC, the clinician is sometimes faced with obscure patient data, and cannot be sure if they are dealing with fCRC or sporadic CRC. The elucidation of what is going on with the as yet "undefined" portion of CRC will aid not only in the diagnosis, classification and treatment of CRC, but more importantly in the proper adjustment of the screening guidelines and in genetic counselling of patients.

Entities:  

Keywords:  Colorectal cancer; Familial; Polymorphisms; Type X; Undefined

Year:  2009        PMID: 21160768      PMCID: PMC2999090          DOI: 10.4251/wjgo.v1.i1.12

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  65 in total

1.  Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.

Authors:  Johanna Skoglund; Bo Song; Johan Dalén; Stefan Dedorson; David Edler; Fredrik Hjern; Jörn Holm; Claes Lenander; Ulrik Lindforss; Nils Lundqvist; Hans Olivecrona; Louise Olsson; Lars Påhlman; Jörgen Rutegård; Kennet Smedh; Anders Törnqvist; Richard S Houlston; Annika Lindblom
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

Review 2.  Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

Authors:  Jeremy R Jass
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

3.  Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.

Authors:  Wade S Samowitz; Hans Albertsen; Carol Sweeney; Jennifer Herrick; Bette J Caan; Kristin E Anderson; Roger K Wolff; Martha L Slattery
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

Review 4.  Colorectal cancer and genetic alterations in the Wnt pathway.

Authors:  S Segditsas; I Tomlinson
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

5.  Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.

Authors:  Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle
Journal:  Nat Genet       Date:  2002-01-30       Impact factor: 38.330

Review 6.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

7.  Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma.

Authors:  T Katoh; N Nagata; Y Kuroda; H Itoh; A Kawahara; N Kuroki; R Ookuma; D A Bell
Journal:  Carcinogenesis       Date:  1996-09       Impact factor: 4.944

Review 8.  Serrated neoplasia of the colorectum.

Authors:  Nathan T Harvey; Andrew Ruszkiewicz
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

9.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

Authors:  P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

10.  National study of colorectal cancer genetics.

Authors:  S Penegar; W Wood; S Lubbe; I Chandler; P Broderick; E Papaemmanuil; G Sellick; R Gray; J Peto; R Houlston
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

View more
  3 in total

1.  Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Yong-Liang Lu; Gai-Ling Li; Hui-Lian Huang; Jing Zhong; Li-Cheng Dai
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  Association between six genetic polymorphisms and colorectal cancer: a meta-analysis.

Authors:  Cheng Chen; Lingyan Wang; Qi Liao; Leiting Xu; Yi Huang; Cheng Zhang; Huadan Ye; Xuting Xu; Meng Ye; Shiwei Duan
Journal:  Genet Test Mol Biomarkers       Date:  2014-02-19

3.  A functional polymorphism rs11614913 in microRNA-196a2 is associated with an increased risk of colorectal cancer although not with tumor stage and grade.

Authors:  Na Wang; Yan Li; Ling-Jun Zhu; Rong-Miao Zhou; Wei Jin; Xiao-Qing Guo; Chun-Mei Wang; Zhi-Feng Chen; Wei Liu
Journal:  Biomed Rep       Date:  2013-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.